Workboat Indexes
Recursion Pharmaceuticals Inc Cl A (NQ: RXRX )
6.320
+0.200
(+3.27%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 10, 2024
Add to My Watchlist
All News about Recursion Pharmaceuticals Inc Cl A
![](https://g.foolcdn.com/editorial/images/776232/doctor-with-patient-talking.jpg)
![](https://investorplace.com/wp-content/uploads/2023/07/rxrx1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/05/09/Genetic-Research-And-Biotech-Science-Con.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2024/05/Stock-SoundHound-01-shutt.jpg)
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![](https://ml.globenewswire.com/media/9c3f7e67-3394-4aee-b77d-68f288ea03a7/small/recursion-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://g.foolcdn.com/editorial/images/771188/two-investors-look-at-figures.jpg)
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://www.globenewswire.com/Content/Images/intrado.png)
Via GlobeNewswire
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://g.foolcdn.com/editorial/images/774134/nvidia-headquarters-with-nvidia-sign-in-front-source-nvidia.png)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://g.foolcdn.com/editorial/images/773876/biopharma-research-and-testing.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/04/24/Jim-Cramer-Photo-by-s-bukley-on-Shutters.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Analyst Scoreboard: 5 Ratings For Recursion Pharmaceuticals
April 09, 2024
Via Benzinga
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
Via Talk Markets
![](https://ml.globenewswire.com/media/cda1f9a1-e6d2-44c8-b51a-f03c6c6a24ef/small/logo-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://investorplace.com/wp-content/uploads/2022/03/cathie-wood-stocks-1600.png)
![](https://images.pexels.com/photos/5849595/pexels-photo-5849595.jpeg?auto=compress&cs=tinysrgb&dpr=1&w=500)
![](https://cdn.benzinga.com/files/images/story/2024/04/11/cathie-wood-bz-ark.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/772140/scientists-looking-at-screen-with-icons.jpg)
![](https://g.foolcdn.com/editorial/images/771562/doctor-explains-situation-to-colleagues.jpg)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
AI Surge Ending: Only One Category Was Up This Week
April 06, 2024
Via Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![](https://g.foolcdn.com/editorial/images/771447/person-sitting-and-working-at-a-desk.jpg)
![](https://www.globenewswire.com/Content/Images/intrado.png)
Recursion to Participate in Upcoming Investor Conference
April 02, 2024
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.